Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer

NCT00489359 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Pemetrexed - Phase 1
DRUG: Carboplatin - Phase 1
DRUG: Pemetrexed - Phase 2
DRUG: Carboplatin - Phase 2

Sponsor

Eli Lilly and Company